S. 4386 · 117th Congress

A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.

Stage
In committee
Sponsor
Mike Braun
Introduced
2022-06-13
Latest action
2022-06-13 · Introduced in Senate

Summary

This bill allows changes to be made to medical devices without the need for supplemental applications or premarket notifications if the changes are made in accordance with a predetermined change control plan.